NewCardio Financial Statements From 2010 to 2025

NewCardio financial statements provide useful quarterly and yearly information to potential NewCardio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on NewCardio financial statements helps investors assess NewCardio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting NewCardio's valuation are summarized below:
Gross Profit
70.8 K
Market Capitalization
49.7 K
Enterprise Value Revenue
0.2084
Revenue
238.6 K
Quarterly Revenue Growth
(0.90)
We have found one hundred nineteen available fundamental ratios for NewCardio, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of NewCardio last-minute fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 15.3 M. Enterprise Value is estimated to decrease to about 15.6 M

NewCardio Total Revenue

310,809

Check NewCardio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewCardio's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 5.6 M, as well as many indicators such as Price To Sales Ratio of 43.12, Dividend Yield of 0.0 or Days Sales Outstanding of 40.43. NewCardio financial statements analysis is a perfect complement when working with NewCardio Valuation or Volatility modules.
  
Check out the analysis of NewCardio Correlation against competitors.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.

NewCardio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.3 M2.6 M3.1 M
Slightly volatile
Total Current Liabilities4.4 M4.2 M3.5 M
Slightly volatile
Other Liabilities1.8 M2.2 M2.5 M
Slightly volatile
Accounts Payable562.5 K556.6 K626.9 K
Slightly volatile
Cash500.2 K526.5 K631.7 K
Slightly volatile
Total Liabilities4.5 M6.9 MM
Very volatile
Total Current Assets3.2 M2.4 M2.9 M
Slightly volatile
Common Stock26.8 K35.3 K30.1 K
Slightly volatile
Property Plant Equipment130.2 K179.7 K146.8 K
Slightly volatile
Net Receivables34.3 K38.6 K42.1 K
Slightly volatile

NewCardio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative5.6 M6.8 M5.7 M
Slightly volatile
Research Development2.5 M4.1 M3.4 M
Slightly volatile
Total Operating Expenses8.2 M11.2 M9.2 M
Slightly volatile

NewCardio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings3.6 M3.5 M2.9 M
Slightly volatile
Depreciation96.5 K91.9 K76.7 K
Slightly volatile
Capital Expenditures40.7 K42.8 K36 K
Slightly volatile
Total Cash From Financing Activities3.4 M3.4 MM
Slightly volatile
Change To Netincome5.5 M5.4 M4.6 M
Slightly volatile
Change To Liabilities185 K176.2 K204.4 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio43.1285.0185.5903
Very volatile
Days Sales Outstanding40.4354.7657.8979
Very volatile
Average Payables322.4 K180.2 K176.7 K
Pretty Stable
Capex To Depreciation1.271.331.4418
Slightly volatile
EV To Sales46.8693.4693.9749
Very volatile
Payables Turnover0.540.570.7746
Slightly volatile
Research And Ddevelopement To Revenue11.1412.5413.6672
Slightly volatile
Capex To Revenue0.340.320.3341
Slightly volatile
Cash Per Share0.02230.02350.0195
Slightly volatile
Days Payables Outstanding701668693
Slightly volatile
Income Quality0.540.460.4266
Very volatile
ROE2.574.183.7137
Slightly volatile
Intangibles To Total Assets0.01550.01750.019
Slightly volatile
Current Ratio1.110.650.7556
Pretty Stable
Receivables Turnover8.286.96.39
Very volatile
Capex Per Share0.00250.00290.003
Pretty Stable
Average Receivables17.2 K19.3 K21.1 K
Slightly volatile
Revenue Per Share0.00980.01030.0147
Slightly volatile
Interest Debt Per Share0.130.11630.1797
Slightly volatile
Debt To Assets0.480.950.9909
Pretty Stable
Graham Number0.00610.00690.0075
Slightly volatile
Operating Cycle40.4354.7657.8979
Very volatile
Price Earnings To Growth Ratio0.04730.04970.1241
Slightly volatile
Days Of Payables Outstanding701668693
Slightly volatile
Ebt Per Ebit2.231.371.4711
Pretty Stable
Return On Capital Employed11.6611.111.7803
Slightly volatile
Quick Ratio1.110.650.7556
Pretty Stable
Net Income Per E B T1.541.171.1089
Very volatile
Cash Ratio0.140.150.1526
Slightly volatile
Days Of Sales Outstanding40.4354.7657.8979
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.820.920.9744
Pretty Stable
Fixed Asset Turnover1.81.898.9159
Slightly volatile
Debt Ratio0.480.950.9909
Pretty Stable
Price Sales Ratio43.1285.0185.5903
Very volatile
Asset Turnover0.09860.10.4172
Slightly volatile
Gross Profit Margin0.280.370.3904
Very volatile
Return On Equity2.574.183.7137
Slightly volatile

NewCardio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap15.3 M21.9 M22.4 M
Pretty Stable
Enterprise Value15.6 M24.1 M24.5 M
Pretty Stable

About NewCardio Financial Statements

Investors use fundamental indicators, such as NewCardio's revenue or net income, to determine how well the company is positioned to perform in the future. Although NewCardio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Revenue296 K310.8 K
Cost Of Revenue175.1 K183.9 K
Research And Ddevelopement To Revenue 12.54  11.14 
Capex To Revenue 0.32  0.34 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(42.26)(40.15)

Currently Active Assets on Macroaxis

When determining whether NewCardio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NewCardio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Newcardio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Newcardio Stock:
Check out the analysis of NewCardio Correlation against competitors.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewCardio. If investors know NewCardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.008
Quarterly Revenue Growth
(0.90)
Return On Assets
(2.24)
The market value of NewCardio is measured differently than its book value, which is the value of NewCardio that is recorded on the company's balance sheet. Investors also form their own opinion of NewCardio's value that differs from its market value or its book value, called intrinsic value, which is NewCardio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewCardio's market value can be influenced by many factors that don't directly affect NewCardio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewCardio's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewCardio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewCardio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.